An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea

Cutis

Volumn 91, Issue 3, 2013, Pages 1-8

  Del Rosso, James Q ^a   Gallo, Richard L ^a   Tanghetti, Emil ^a   Webster, Guy ^a   Thiboutot, Diane ^a  

^a VALLEY HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID; DOXYCYCLINE; METRONIDAZOLE; TOLL LIKE RECEPTOR 2;

CLASSIFICATION; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; LOW LEVEL LASER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; ROSACEA; SKIN; TELANGIECTASIA; TH1 CELL; VASCULARIZATION; VASODILATATION;

DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DOXYCYCLINE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LASER THERAPY, LOW-LEVEL; METRONIDAZOLE; ROSACEA; SKIN; TELANGIECTASIS; TH1 CELLS; TOLL-LIKE RECEPTOR 2; VASODILATION;

EID: 84888417644     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)